Literature DB >> 18349097

Genomic profiles for disease risk: predictive or premature?

Kenneth Offit1.   

Abstract

Mesh：

Year:  2008        PMID： 18349097     DOI： 10.1001/jama.299.11.1353

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  46 in total

1.  Preferences for genetic and behavioral health information: the impact of risk factors and disease attributions.

Authors:  Suzanne C O'Neill; Colleen M McBride; Sharon Hensley Alford; Kimberly A Kaphingst
Journal:  Ann Behav Med       Date:  2010-10

2.  Genetic counseling and the ethical issues around direct to consumer genetic testing.

Authors:  Alice K Hawkins; Anita Ho
Journal:  J Genet Couns       Date:  2012-06       Impact factor: 2.537

3.  Which way for genetic-test regulation? Assign regulation appropriate to the level of risk.

Authors:  Gail Javitt
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

4.  Personal genomics and individual identities: motivations and moral imperatives of early users.

Authors:  Michelle L McGowan; Jennifer R Fishman; Marcie A Lambrix
Journal:  New Genet Soc       Date:  2010-09-01

5.  Using lessons learned from BRCA testing and marketing: what lies ahead for whole genome scanning services.

Authors:  Michelle L McGowan; Jennifer R Fishman
Journal:  Am J Bioeth       Date:  2008-06       Impact factor: 11.229

Review 6.  Developing the blueprint for a genetic testing registry.

Authors:  G Javitt; S Katsanis; J Scott; K Hudson
Journal:  Public Health Genomics       Date:  2009-06-29       Impact factor: 2.000

7.  Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?

Authors:  Caroline Fiona Wright; Mark Kroese
Journal:  Hum Genet       Date:  2009-11-20       Impact factor: 4.132

Review 8.  Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.

Authors:  Frauke Becker; Carla G van El; Dolores Ibarreta; Eleni Zika; Stuart Hogarth; Pascal Borry; Anne Cambon-Thomsen; Jean Jacques Cassiman; Gerry Evers-Kiebooms; Shirley Hodgson; A Cécile J W Janssens; Helena Kaariainen; Michael Krawczak; Ulf Kristoffersson; Jan Lubinski; Christine Patch; Victor B Penchaszadeh; Andrew Read; Wolf Rogowski; Jorge Sequeiros; Lisbeth Tranebjaerg; Irene M van Langen; Helen Wallace; Ron Zimmern; Jörg Schmidtke; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2011-04       Impact factor: 4.246

Review 9.  Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.

Authors:  J Scott Roberts; Wendy R Uhlmann
Journal:  Prog Neurobiol       Date:  2013-04-09       Impact factor: 11.685

10.  Disclosure of APOE genotype for risk of Alzheimer's disease.

Authors:  Robert C Green; J Scott Roberts; L Adrienne Cupples; Norman R Relkin; Peter J Whitehouse; Tamsen Brown; Susan LaRusse Eckert; Melissa Butson; A Dessa Sadovnick; Kimberly A Quaid; Clara Chen; Robert Cook-Deegan; Lindsay A Farrer
Journal:  N Engl J Med       Date:  2009-07-16       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.